Related Experiment Video
Updated: Jun 22, 2026

Investigating Intestinal Inflammation in DSS-induced Model of IBD
Published on: February 1, 2012
Dermatological signs during inflammatory bowel diseases
C Feliciani1, C De Simone, P Amerio
1Department of Dermatology, Catholic University of the Sacred Heart, Rome, Italy. feliciani@rm.unicatt.it
Dermatologists may identify inflammatory bowel disease (IBD) through skin conditions like pyoderma gangrenosum and erythema nodosum. Early skin lesion diagnosis can lead to timely treatment for Crohn
Area of Science:
- Gastroenterology and Dermatology
- Internal Medicine
Background:
- Crohn disease (CD) and ulcerative colitis (UC) are inflammatory bowel diseases (IBD) characterized by bowel ulcerations.
- Skin, oral, or perianal lesions can manifest in IBD patients, sometimes preceding bowel symptoms.
- Dermatologists may encounter skin conditions that indicate underlying IBD.
Purpose of the Study:
- To highlight the association between specific dermatological conditions and inflammatory bowel disease.
- To emphasize the role of dermatologists in suspecting and diagnosing IBD based on skin manifestations.
Main Methods:
- Review of clinical presentations linking dermatological findings to IBD.
- Analysis of common skin lesions associated with IBD, including pyoderma gangrenosum (PG) and erythema nodosum (EN).
Main Results:
- Pyoderma gangrenosum and erythema nodosum are well-recognized dermatological signs associated with IBD.
- Skin lesions can be the initial presentation of IBD, prompting further investigation.
- The presence of these skin conditions necessitates consideration of underlying bowel pathology.
Conclusions:
- Dermatological manifestations like PG and EN can serve as crucial early indicators of IBD.
- Collaboration between dermatology and gastroenterology is vital for comprehensive patient care.
- Treatment for IBD, when indicated by skin lesions, may range from corticosteroids to anti-TNF biologics.
More Related Videos
08:58Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
09:11Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulfate-Induced Colitis Model
Published on: February 14, 2021
Related Concept Videos
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease IV: Clinical Manifestations
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Ulcerative Colitis
Inflammatory Bowel Disease I: Introduction
Inflammatory Bowel Disease III: Crohn's Disease